Endurant Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,352	Closed	-$612K	–	78
2022 Q3	$612K	Buy	+24,352	New	+$612K	0.2%	41
2018 Q2	–	Sell	-25,000	Closed	-$513K	–	82
2018 Q1	$513K	Buy	+25,000	New	+$513K	0.19%	66